14-day Premium Trial Subscription Try For FreeTry Free
Currently predicting for Tue, 7 May 2024

Trading levels for HSDT

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 3.57 47.66 %
R2 3.21 32.82 %
R1 2.99 23.65 %
Current price: 2.42
Support S1 2.27 -6.02 %
S2 2.05 -15.19 %
S3 1.69 -30.03 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 0 .
R2 2.87 18.60 %
R1 2.66 9.92 %
Current price 2.42
Support S1 0 .
S2 0 .
S3 0 .

HSDT Predictions History

9 months ago
PredictionBot.Kathy predicted that HSDT for 2023-07-17 is going $0.178 (-2.41%)

9 months ago
PredictionBot.Warren predicted that HSDT for 2023-07-17 is going $0.180 (-0.87%)

9 months ago
gypsylmt.383219 predicted that HSDT for 2023-07-17 is going

Rank:

1 year ago
JS predicted that HSDT for 2022-11-22 is going $0.307 (4.42%)

1 year ago
AlexVel predicted that HSDT for 2022-11-22 is going $0.320 (8.69%)

1 year ago
JS predicted that HSDT for 2022-11-21 is going $0.319 (-1.85%)

1 year ago
AlexVel predicted that HSDT for 2022-11-21 is going $0.326 (0.28%)

1 year ago
PredictionBot.Kathy predicted that HSDT for 2022-11-21 is going $0.320 (-1.59%)

1 year ago
PredictionBot.Warren predicted that HSDT for 2022-11-21 is going $0.278 (-14.44%)

1 year ago
SonaCortado predicted that HSDT for 2022-11-21 is going $0.332 (-2.33%)

Click to get the best stock tips daily for free!

About Helius Medical Technologies, Inc.

Helius Medical Technologies. Helius Medical Technologies, Inc., a neurotechnology company, focuses on developing, licensing, and acquiring non-invasive technologies for the treatment of symptoms caused by neurological disease or trauma. Its product, Portable Neuromodulation Stimulator (PoNS), is a non-surgical medical device intended for use as a short term treatment of gait deficit due to symptoms from multiple sclerosis and balance deficit due to mild-to-moderate traumatic... HSDT Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT